Harel Insurance Investments & Financial Services Ltd. Uro Gen Pharma Ltd. Transaction History

Harel Insurance Investments & Financial Services Ltd.

$6.11 Billion
Q4 2024

A detailed history of Harel Insurance Investments & Financial Services Ltd. transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Harel Insurance Investments & Financial Services Ltd. holds 463,267 shares of URGN stock, worth $4.38 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

463,267

Previous 463,267 -0.0%

Holding current value

$4.38 Million

Previous $5.88 Million 16.13%

% of portfolio

0.08%

Previous 0.1%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$12.7 - $17.92 $3,784 - $5,340	-298 Reduced 0.06%	463,267 $5.88 Million
Q2 2024 Jul 22, 2024	SELL	$12.72 - $19.2 $2.67 Million - $4.03 Million	-209,922 Reduced 31.17%	463,565 $7.78 Million
Q1 2024 Apr 30, 2024	SELL	$13.81 - $19.33 $2.71 Million - $3.8 Million	-196,558 Reduced 22.59%	673,487 $10.1 Million
Q4 2023 Jan 30, 2024	SELL	$10.87 - $15.93 $1,619 - $2,373	-149 Reduced 0.02%	870,045 $13.1 Million
Q3 2023 Oct 30, 2023	SELL	$8.84 - $22.64 $1.37 Million - $3.52 Million	-155,373 Reduced 15.15%	870,194 $12.2 Million
Q2 2023 Jul 17, 2023	SELL	$8.75 - $14.29 $2,633 - $4,301	-301 Reduced 0.03%	1,025,567 $10.6 Million
Q1 2023 May 02, 2023	BUY	$7.99 - $11.02 $2,460 - $3,394	308 Added 0.03%	1,025,868 $9.48 Million
Q4 2022 Jan 26, 2023	SELL	$7.55 - $11.96 $173 - $275	-23 Reduced -0.0%	1,025,560 $9.1 Million
Q3 2022 Oct 31, 2022	SELL	$7.21 - $9.41 $201 - $263	-28 Reduced -0.0%	1,025,583 $8.53 Million
Q2 2022 Jul 19, 2022	SELL	$5.12 - $8.74 $112 - $192	-22 Reduced -0.0%	1,025,611 $8.4 Million
Q1 2022 May 03, 2022	SELL	$5.92 - $9.73 $248 - $408	-42 Reduced -0.0%	1,025,633 $8.93 Million
Q4 2021 Feb 07, 2022	BUY	$9.03 - $19.13 $9.26 Million - $19.6 Million	1,025,675 New	1,025,675 $9.75 Million
Q3 2019 Nov 06, 2019	SELL	$23.83 - $36.44 $71,490 - $109,320	-3,000 Closed	0 $0
Q2 2019 Jul 22, 2019	BUY	$32.75 - $40.35 $32,750 - $40,350	1,000 Added 50.0%	3,000 $108,000
Q1 2019 Apr 18, 2019	BUY	$35.47 - $54.55 $35,470 - $54,550	1,000 Added 100.0%	2,000 $74,000
Q4 2018 Jan 29, 2019	SELL	$38.35 - $50.39 $61,360 - $80,624	-1,600 Reduced 61.54%	1,000 $43,000
Q2 2018 Jul 30, 2018	BUY	$48.35 - $65.33 $125,710 - $169,858	2,600 New	2,600 $129,000

Others Institutions Holding URGN

# of Institutions

137

Shares Held

36.2M

Call Options Held

57.7K

Put Options Held

9.8K

View Full List

About UroGen Pharma Ltd.

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $215M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

More about URGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Account

Harel Insurance Investments & Financial Services Ltd. Uro Gen Pharma Ltd. Transaction History